U.S. flag An official website of the United States government
  1. Home
  2. Emergency Preparedness and Response
  3. Counterterrorism and Emerging Threats
  4. Medical Countermeasures Initiative (MCMi)
  5. Medical Countermeasures Initiative Collaborations
  6. Other MCMi Collaborations (Non-Government Organizations)
  1. Medical Countermeasures Initiative Collaborations

Other MCMi Collaborations (Non-Government Organizations)

Image representing collaborative partnerships

In addition to extensive work with U.S. government agencies, FDA works with a variety of other non-government organizations (NGOs)—domestic and international—to support development of and access to medical countermeasures, or MCMs. These Medical Countermeasures Initiative (MCMi) partnerships include, but are not limited to, the following examples.

National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division (NASEM-HMD) 

FDA participates in the Forum on Medical and Public Health Preparedness for Disasters and Emergencies to provide national leadership in coordinating ongoing efforts among members from federal, state, and local government; business; and professional associations to develop sustainable partnerships between the public and private sector so that communities are adequately prepared for natural or human-made catastrophic events.

National Association of County and City Health Officials (NACCHO)

FDA actively participates in and contributes to planning of the annual public health Preparedness Summit, and works with NACCHO and other organizations to support state, tribal, local, and territorial public health preparedness. 

Bill and Melinda Gates Foundation

In 2017, FDA and the Bill and Melinda Gates Foundation signed an MOU establishing a framework to facilitate collaboration to carry out common goals to improve public health by stimulating and fostering medical product innovation and enabling medical product development, including medical countermeasures. Continued collaborations under this MOU include a broad range of topics such as developing over-the-counter influenza diagnostics, identifying immune correlates of protection for vaccines of public health significance, and developing animal models to support the evaluation of vaccines.

Advanced manufacturing public-private partnerships

To proactively address challenges presented by advanced and continuous manufacturing technologies, FDA representatives actively participate in ongoing public-private partnerships. These partnerships include U.S. government agencies, academia, research institutes, and industry. See, for example: FDA Efforts to Connect Manufacturers and Health Care Entities: The FDA, Department of Veterans Affairs, National Institutes of Health, and America Makes Form a COVID-19 response Public-Private Partnership

MCM regulatory science collaborations

To help develop solutions to complex regulatory science challenges, FDA funds MCM-related regulatory science through intramural and extramural research grants. The goal of the MCMi regulatory science program is to develop the tools, standards, and approaches to assess medical countermeasure safety, efficacy, quality, and performance and to help translate cutting-edge science and technology into innovative, safe, and effective MCMs. Learn more: MCM Regulatory Science

Contact us

Want to partner with FDA on MCM-related initiatives? Contact AskMCMi@fda.hhs.gov

Related links



Sign up to receive email alerts on emergency preparedness and response topics from FDA, including medical countermeasures and emerging infectious diseases.

Back to Top